ACR Convergence 2026 Archives - ACR Meeting Abstracts

Abstract Number: 1612

Damage in IgG4-related disease
Abstract Number: 2812

Damaged glomeruli in proliferative pediatric lupus nephritis exhibit complement 5a receptor-1 induced fibrotic transcriptional programs
Abstract Number: 2195

Dapagliflozin in Lupus Nephritis: Favorable Real-World Outcomes in a Chilean Cohort
Abstract Number: 2196

Dapirolizumab Pegol Treatment Resulted in Sustained Attainment of Low Disease Activity and Remission in Patients with Systemic Lupus Erythematosus: 48-Week Results from a Phase 3 Trial
Abstract Number: 0165

Data driven machine learning model for long-term mortality prediction in Takayasu Arteritis
Abstract Number: 0880

Data-Driven Clinical Signatures Shape Distinct Longitudinal Disease Trajectories in Psoriatic Arthritis
Abstract Number: 2823

Data-Driven Clustering Identifies Distinct Symptom-Inflammation Phenotypes in Active Rheumatoid Arthritis
Abstract Number: 0262

Data-Driven Glucocorticoid Exposure Trajectories and Predictors of High-Dose Use in Lupus Nephritis
Abstract Number: 1941

Data-Driven Identification of Clinical Phenotypes in Behçet’s Syndrome Using Unsupervised Machine Learning in a Non-Endemic Setting
Abstract Number: 1258

Data-Driven Metabotype Predicts Cardiovascular Outcomes in Systemic Lupus Erythematosus: A Prospective Cohort Study
Abstract Number: 1153

Data-Driven Phenotyping Identifies Six Distinct Clinical and Prognostic Patterns in ANCA-Associated Vasculitis
Abstract Number: 0736

De Novo Inflammatory Arthritis Following Immune Checkpoint Inhibitor Therapy: A Single-Center Real-World Retrospective Study Using the i2b2 Data Repository
Abstract Number: 2719

Decentralized Trials Readiness and Digital Innovation in Lupus Clinical Research: LuCIN Network Site Assessment Survey
Abstract Number: 1703

Declining Mortality but Persistent Inequities: Demographic Disparities in Systemic Lupus Erythematosus Mortality in the United States, 1999-2020
Abstract Number: 0043

Decoupling Interferon and Neutrophil Gene Signatures in Systemic Lupus Erythematosus: A Cross-Sectional Transcriptomic Analysis
Abstract Number: 1800

Decreased Dependence on Disease Modifying Antirheumatic Drugs (DMARDs) Following Lifestyle and Behavior Modifications Through Shared Medical Appointments
Abstract Number: 0263

Deep Depletion of Tissue-Resident B Cells by in vivo CD19 CAR T-Cell Therapy (HN2301) Induces Profound Clinical Remission in Patients with Systemic Lupus Erythematosus.
Abstract Number: 1650

Deep Learning Detection of Intra-Articular Calcification on Knee Computed Tomography
Abstract Number: 0893

Deep Learning for Assessment of Disease Activity in Patients with Axial Spondyloarthritis Using Combined Sacrum and Spine MRI Sacrum and Spine MRI
Abstract Number: 2243

Deep Learning Prediction of Autoantibodies From ANA Immunofluorescence Images
Abstract Number: 0958

Deep Profiling of the Peripheral Immune Landscape and Inflammatory environment in Behçet’s Disease
Abstract Number: 0305

Deep Renal Response at 24 months in Lupus Nephritis
Abstract Number: 1850

Defining A Signature of Autoreactive CD8+ T Cells in HLA-B27-Associated Autoimmune Disease
Abstract Number: 1825

Defining an MRI Indicative of Axial Spondyloarthritis in the Sacroiliac Joints of Patients with Axial Spondyloarthritis: A Data-Driven and Consensus-based Framework of Recommendations by the Spondyloarthritis Research and Treatment Network and the Society of Skeletal Radiology
Abstract Number: 0357

Defining Meaningful Change in ASAS-HI in Patients With Axial Spondyloarthritis: Associations With Core Outcomes and Discrimination of Thresholds of Change in Late Phase Clinical Trials of Upadacitinib
Abstract Number: 0025

Defining Molecular Drivers of Progressive Pulmonary Fibrosis in Systemic Autoimmune Rheumatic Disease
Abstract Number: 2891

Defining Pathogenic PR3-ANCA Through Functional and Structural Profiling
Abstract Number: 2616

Defining the contributors to sudden cardiac death in sarcoidosis: a nationwide study
Abstract Number: 1984

Defining the Molecular Landscape of Lupus Nephritis by Comparative Transcriptomic Profiling
Abstract Number: 0026

Defining the role of TEADs and VGLL3 in scleroderma endothelial cells
Abstract Number: 2617

Definition of overlapping and mixed autoinflammatory disorders in patients carrying multiple autoinflammatory variants in a cohort of 483 patients followed at a tertiary referral centre
Abstract Number: 1188

Delayed Gastric Emptying Is Associated with Cardiovagal Dysfunction and Supine Hypertension in Systemic Sclerosis: A Single-Center Cross-Sectional Analysis of Paired Autonomic and Gastric Emptying Testing
Abstract Number: 0027

Delineating m6A RNA methylation in systemic sclerosis identifies demethylase FTO as a therapeutic target for fibrosis
Abstract Number: 2244

Delirium in SLE: An Underrecognized Neuropsychiatric Manifestation Associated with High Disease Activity
Abstract Number: 1704

Demographic Reporting Transparency in Biologic Trials for Axial Spondyloarthritis (2009-2025)
Abstract Number: 0783

Demographic Trends in U.S. Rheumatology Fellowship Trainees, 2005-2023: A Longitudinal Analysis
Abstract Number: 0840

Demographic, Clinical, and Treatment Differences Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in a Large U.S. Rheumatology Network
Abstract Number: 1563

Demographical profile of patients included in a FLS (Fracture Liaison Service) and impact on patient’s management after a fragility fracture – A longitudinal FLS evaluation
Abstract Number: 0807

Demyelinating Events During Exposure To TNF-Inhibitors Compared To CsDMARDs In Patients With Rheumatoid Arthritis: Results From The French National Healthcare Database
Abstract Number: 2954

Denosumab Treatment Significantly Enhances Bone Remodeling and Bone Mineral Density in Rheumatic Diseases Patients with Osteropenia/Osteoporosis：An Prospective Cohort Study
Abstract Number: 2553

Denosumab Versus Bisphosphonates and Osteoporotic Fracture Risk in Chronic Glucocorticoid Users: A Propensity-Matched Real-World Analysis
Abstract Number: 1438

Derivation and External Validation of FLARE-RA Thresholds for Rheumatoid Arthritis Flares
Abstract Number: 1965

Dermal Adipocytic Cells Play a Critical Role in Early Skin Fibrosis by Contributing to Fibrogenesis
Abstract Number: 0563

Design of a Visual Tool to Incorporate Personalized Predictive Information about Treatment Effectiveness in Clinical Conversations about Juvenile Idiopathic Arthritis
Abstract Number: 0841

Despite Improving Trends, Gaps Persist in Pneumocystis jirovecii Pneumonia Prophylaxis During High-Dose Glucocorticoid Therapy Across Autoimmune Diseases: A Multi-Decade National Cohort Analysis
Abstract Number: 1613

Destructive Arthritis in Whipple’s disease. A Single-Center Case Series of Twenty Patients
Abstract Number: 0564

Detailing the Diagnostic Process: Utilization Patterns and Harm Indicators Preceding Juvenile Idiopathic Arthritis Diagnosis
Abstract Number: 1103

Detection of Co-Localized B-Lymphocyte Stimulator (BLyS) and B cells in a Perivascular Region in Systemic Sclerosis Skin using Xenium Spatial Omics
Abstract Number: 1054

Detection of Per- and Polyfluoroalkyl Substances (PFAS) in Serum and Public Water Systems and Risk of Future Onset of Rheumatoid Arthritis in Autoantibody-Positive Individuals
Abstract Number: 1501

Determining Longitudinal Outcomes of Childhood Neuropsychiatric Lupus: A CARRA Registry Study
Abstract Number: 2291

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Phase 3 Trials for PsA: Achievement of Minimal Disease Activity, Individual Components, and Very Low Disease Activity Through Week 52
Abstract Number: 0968

Development and Characterization of IEX6014, A Novel IL-6 x TL1A BsAb, With Broader and Deeper Inhibition of Disease-driving Mechanisms
Abstract Number: 2962

Development and Initial Implementation of a Consultative Physical Therapy for Rheumatology Program
Abstract Number: 0197

Development and Validation of a Claims-Based Algorithm for Relapse Detection in Granulomatosis With Polyangiitis and Microscopic Polyangiitis
Abstract Number: 2493

Development and Validation of a Computable Phenotype for Pediatric ANCA-Associated Vasculitis Using Multicenter Electronic Health Record Data
Abstract Number: 2589

Development and Validation of a Novel Muscle Ultrasound-Based Myositis Disease Activity Index
Abstract Number: 1719

Development and Validation of an Interactive Chatbot as a Screening Tool for Inflammatory Arthritis : A Single-Centre Pilot Study
Abstract Number: 0198

Development and Validation of Claims-Based Algorithms for Estimating the Birmingham Vasculitis Activity Score (BVAS) in Granulomatosis with Polyangiitis and Microscopic Polyangiitis
Abstract Number: 1062

Development and Validation of Machine Learning (ML)-Based Algorithm for Automated Detection of Active Disease Lesions in Whole Body Magnetic Resonance Imaging (WBMRI) from Children with Chronic Nonbacterial Osteomyelitis (CNO)
Abstract Number: 0883

Development and Validation of the Reactive Arthritis and Peripheral Spondyloarthritis Activity Score (RAPSAS)
Abstract Number: 1502

Development and Validation of Thresholds Defining Disease Activity States for the Juvenile Spondyloarthritis Disease Activity Score
Abstract Number: 0546

Development of a Competency-Based Musculoskeletal Ultrasound Curriculum for Rheumatology Fellows
Abstract Number: 0306

Development of a Composite Risk Score Integrating Genetic, Clinical, and Environmental Factors for Predicting Systemic Lupus Erythematosus
Abstract Number: 1876

Development of a Core Health Care Transition Outcomes Set for Adolescents and Young Adults with Juvenile Idiopathic Arthritis Transitioning from Pediatric to Adult Rheumatology Care
Abstract Number: 1870

Development of a Deep Learning-Based Tool for Automated Assessment of Synovitis, Power-Doppler Activity, Erosions, and Osteophytes and Classification of Arthritis Using Ultrasound Imaging.
Abstract Number: 1833

Development of a dried-bloodspot ACPA test for population-based screening of RA autoimmunity
Abstract Number: 2357

Development of a patient-derived 3D epithelial-immune co-culture model to recapitulate the glandular microenvironment in Sjögren’s disease
Abstract Number: 2018

Development of a Patient-Derived 3D Synovial Organoid Platform for Personalized Drug Testing in Rheumatoid Arthritis
Abstract Number: 2170

Development of a Quantitative Ultrasound Composite Score for Microstructural Assessment of Systemic Sclerosis Skin
Abstract Number: 0446

Development of a Serum Proteomic Signature for Predicting Response to the Adalimumab Biosimilar BAT1406 in Rheumatoid Arthritis: Beyond Clinical Prediction Models
Abstract Number: 0910

Development of an AI-based risk calculator for perinatal psychiatric disorders: clinical pilot with digital synthetic twins
Abstract Number: 1373

Development of Clinical Practice Guideline for the Evaluation and Management of Central Nervous System Manifestations in Sjögren’s Disease
Abstract Number: 2324

Development of Extra-musculoskeletal Manifestations in Upadacitinib-Treated Patients With Spondyloarthritis: Long-Term Evidence From Clinical Programs and Real-World Data
Abstract Number: 0611

Development of Patient Educational Materials to Support Shared Decision Making at the Time of Juvenile Idiopathic Arthritis Diagnosis
Abstract Number: 0593

Development of the LupusCoach Chatbot: Results from Testing
Abstract Number: 1852

Developmental Sacral Fusion Defines a Biologically Relevant Model for Studying Pathological Ankylosis in Axial Spondyloarthritis
Abstract Number: 0808

Device Utilization, Immunosuppressive Therapy, and Clinical Outcomes in Cardiac Sarcoidosis: A Real-World EPIC Cosmos Analysis
Abstract Number: 2927

Diabetes Risk in Rheumatoid Arthritis Has Not Improved Over the Modern Treatment Era
Abstract Number: 2821

Diagnostic Accuracy of Brief Fibromyalgia Screening Tools in Adults with Chronic Pain: A Systematic Review and Meta-Analysis
Abstract Number: 0485

Diagnostic Accuracy of Serum 14-3-3η Protein in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Abstract Number: 2102

Diagnostic Performance of Imaging Modalities and Temporal Artery Biopsy in Giant Cell Arteritis According to Symptom Profile and Glucocorticoid Exposure: A French Cohort Study
Abstract Number: 1691

Diagnostic Performance of Lung Ultrasound for Detection of Interstitial Lung disease In Connective Tissue Diseases: A Systematic Review and Meta-Analysis
Abstract Number: 2691

Diagnostic Performance of Musculoskeletal Ultrasound for Detecting Low Appendicular Lean Mass in Adults at Risk of Osteosarcopenia
Abstract Number: 2358

Diagnostic Utility of Novel/Early Anti-Epithelial Antibodies in Sjögren’s Disease: A Retrospective Study
Abstract Number: 2103

Diagnostic Value of the Skin Pathergy Test with Polysaccharide Pneumococcal Vaccine Antigens in Individuals Referred for Behçet’s Syndrome Screening
Abstract Number: 1720

Diagnostic Yield, Treatment Changes, and Emergency Department Utilization Following Initial Evaluation in an Interdisciplinary Dermatology-Rheumatology Clinic
Abstract Number: 1741

DIAPS evolution among antiphospholipid antibody carriers: impact of serological profile, associated diseases and primary thromboprophylaxis.
Abstract Number: 1903

Dietary Fibre Supplementation improves Rheumatoid Arthritis and Th17/Treg Balance : Results from the SUPERFIBRES Randomized Controlled Trial
Abstract Number: 1890

Differences in Patient Characteristics and Health-Related Quality of Life Between Controlled and Uncontrolled Gout
Abstract Number: 1841

Differences in the Risk of Allopurinol Hypersensitivity Syndrome Among Subgroups Defined by Self-Reported Race: An Analysis of Real-World Data in U.S. Patients with Gout
Abstract Number: 1030

Differential expression of plasma microRNAs in psoriatic arthritis and skin psoriasis hints at diverse but overlapping mechanisms
Abstract Number: 2008

Differential Gene Expression Associated with Coronary Artery Calcium Severity in Axial Spondyloarthritis
Abstract Number: 2423

Differential impact of rheumatoid factor levels on biologic persistence in rheumatoid arthritis: non-TNF inhibitors versus certolizumab pegol
Abstract Number: 1503

Differential Methylation Characterizes Infants with Cardiac Neonatal Lupus Erythematosus Compared to Unaffected Infants Born to Anti-Ro Positive Mothers
Abstract Number: 1742

Differential Mortality Risk in Septic Shock Among Patients With Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Sjögren Syndrome
Abstract Number: 2044

Differential Transcript Usage Reveals Immune-Associated Isoform Switching in Juvenile Localized Scleroderma
Abstract Number: 1340

Difficult-to-Manage and Treatment-Refractory Axial Spondyloarthritis: Clinical and Radiographic Characterization of a Single-Center Cohort
Abstract Number: 1504

Difficult-to-Treat Juvenile Idiopathic Arthritis: Insights into Treatment Refractory Disease
Abstract Number: 0881

Difficult-to-Treat Psoriasis Identifies Patients at Increased Risk of Incident Psoriatic Arthritis: A Population-Based Time-Varying Cohort Study
Abstract Number: 1407

Difficult-to-treat Rheumatoid arthitis is a Dynamyc Condition: Longitudinal Patterns and Drivers of D2T Status over Time
Abstract Number: 0809

Difficult-to-Treat Rheumatoid Arthritis in China: Prevalence, Phenotypes, and Real-World Clinical Outcomes
Abstract Number: 2554

Diffuse Cutaneous Subtype, Pulmonary Impairment and Clucocorticoids are Key Determinants of Osteoporosis in Systemic Sclerosis: Evidence from Cross-sectional and Longitudinal Analyses
Abstract Number: 1692

Diffusion Weighted ADC Maps with STIR Improve Rater Diagnostic Reliability, Accuracy and Confidence for Sacroiliitis Across Skeletal Maturation Stages
Abstract Number: 1127

Direct IL-6 Inhibition with Olokizumab in Patients with Polymyalgia Rheumatica: Efficacy and Safety Results from the Phase 3 PROMISE Trial
Abstract Number: 2393

Direct IL‑6 Inhibition with Olokizumab Corrects Anemia in Rheumatoid Arthritis
Abstract Number: 2799

Direct Oral Anticoagulants Versus Warfarin in Antiphospholipid Syndrome: A Propensity-Matched Real-World Analysis of Recurrent Thrombosis, Bleeding, and Mortality
Abstract Number: 1651

Discontinuation of Gout-associated Medications among Patients with Gout Admitted to the Hospital
Abstract Number: 0842

Discordance between Patient and Physician Perspectives on Hydroxychloroquine Blood Level Testing and Co-Designing Strategies to Improve Adoption in Clinics
Abstract Number: 0307

Discordance Between Physician and Patient Global Assessment of Disease Activity in a Large Multicenter Prospective SLE Cohort in the U.S. and Canada
Abstract Number: 1942

Discordance Between Virologic Cure and Immunologic Remission in HCV-Associated Cryoglobulinemic Vasculitis in the Direct-Acting Antiviral Era: A Systematic Review
Abstract Number: 2934

Discordant Synovial Pathology and Ultrasound Scores in Early vs Refractory Rheumatoid Arthritis
Abstract Number: 0784

Discovering Patterns of Healthcare Utilization Trajectories Preceding the Diagnosis of Systemic Lupus Erythematosus: A Population-Based Study.
Abstract Number: 0081

Discovery and Preclinical Characterization of FT2109, a Differentiated Oral TNFR1 Signaling Inhibitor
Abstract Number: 1985

Discovery of Extracellular Autoantibodies in Systemic Lupus Erythematosus
Abstract Number: 1439

Disease activity and long-term kidney function trajectories in rheumatoid arthritis: a Japanese nationwide registry cohort study using the NinJa database
Abstract Number: 1259

Disease Activity and Patient-Reported Outcomes Among Patients With Systemic Lupus Erythematosus Receiving Low-Dose Glucocorticoids: Results From a Real-World Study
Abstract Number: 2325

Disease Activity Improvement Predicts Work Productivity Gains Following Biologic Therapy Changes in Ankylosing Spondylitis: A Real-World Longitudinal Analysis
Abstract Number: 1260

Disease Activity Trajectories, Treat-to-Target Attainment, and Damage Accrual in a Real-World Systemic Lupus Erythematosus Cohort
Abstract Number: 1261

Disease Activity, Organ Damage, and Treatment Exposure in Systemic Lupus Erythematosus With Neuropsychiatric Involvement: Insights from the Lupus Federated Data Network (LupusNet)
Abstract Number: 0810

Disease Burden, Diagnostic Delay and Clinical Profile for AxSpA in LA: A Systematic Literature Review and Metaanalysis
Abstract Number: 2359

Disease Burden, Fragmented Care and Healthcare Utilization in Sjögren’s Disease Compared with Rheumatoid Arthritis
Abstract Number: 2104

Disease Presentation and Course of Pediatric-Onset Behçet’s Disease Across Pediatric and Adulthood Period According to Classification Criteria Fulfillment
Abstract Number: 2424

Disease-Modifying Anti-rheumatic Drugs (DMARDs) use and mortality after Genitourinary (GU) Cancer Diagnosis in patients with Rheumatoid Arthritis (RA)
Abstract Number: 2703

Disease-Modifying Antirheumatic Drug Order Capture Among Rheumatoid Arthritis-Coded Adults in an Underserved Outpatient Cohort
Abstract Number: 2742

Disease-Specific Autoimmune Phenotypes in Myocarditis: A Nationwide Analysis of Arrhythmias, Shock, and Mortality
Abstract Number: 2704

Disparities in Lupus Research Participation and Resources at Sites with High Proportions of Black, Hispanic and Medicaid-insured Patients
Abstract Number: 1531

Disparities in Plain Sight: Predictors of Low Self-Management Confidence in Medically Underserved Adults with Musculoskeletal Conditions
Abstract Number: 2705

Disparities in Semaglutide Access despite Universal Health Care among Adults with Rheumatic Diseases and Diabetes
Abstract Number: 2706

Disparities in Temporal Artery Biopsy Utilization, Timeliness, and In-Hospital Outcomes Among Patients Hospitalized With Giant Cell Arteritis: A National Inpatient Sample Analysis
Abstract Number: 1311

Disproportionality Analysis of Biologic Therapies in Spondyloarthritis: Assessing the Risk of Infections
Abstract Number: 1866

Dissecting SLE Metabolomics in Lupus Nephritis
Abstract Number: 2946

Distinct Baseline Molecular Endotypes but Convergent Responses to Ustekinumab in Psoriatic Arthritis: Longitudinal Multi-Omics Analyses from the Randomised MUST Trial
Abstract Number: 2673

Distinct Cancer Outcomes in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis and Arthralgia
Abstract Number: 0654

Distinct Clinical and Radiographic Phenotypes in Anti-MDA5-Positive vs Negative IIM-Associated Interstitial Lung Disease: A Comparative Analysis Incorporating CT-Derived Pulmonary Vascular Biomarkers
Abstract Number: 2057

Distinct Clonal Expansions of GZMB+ CD8+ Terminally Differentiated Effector Memory T (TEMRA) Cells Characterize Blood of Inclusion Body Myositis Patients
Abstract Number: 0655

Distinct Creatine Kinase Trajectory Phenotypes Identified by Latent Class Mixed Modeling Are Discordant with Clinical Outcomes in Idiopathic Inflammatory Myopathies
Abstract Number: 1341

Distinct Distribution and Longitudinal Decrease of Spinal MRI Inflammatory Lesions Differentiate Early Axial Spondyloarthritis from Chronic Back Pain
Abstract Number: 1374

Distinct Factors Associated with Patient-Reported Symptom Burden and Systemic Disease Activity in Sjögren’s Disease
Abstract Number: 1375

Distinct ILD Phenotypes across Rheumatoid Arthritis, Sjögren Disease, and RA-Sjögren Overlap: Multicenter Registry Findings
Abstract Number: 0756

Distinct Joint Distribution and Graded Radiographic Severity across HFE associated arthropathy phenotypes.
Abstract Number: 2050

Distinct lining fibroblast states define healthy and osteoarthritic human synovium
Abstract Number: 0913

Distinct Mental Health Phenotypes in Rheumatoid Arthritis Identified Through Clinically Significant Psychological Burden Clustering
Abstract Number: 2326

Distinct Metabolic Phenotypes in Spondyloarthritis: Differential Associations Between Metabolic Syndrome and Disease Activity in Psoriatic Arthritis and Axial Spondyloarthritis
Abstract Number: 0948

Distinct Microbiome and MetabolomicMulti-omic Trajectories Associated with Clinical Response to Two Anti-inflammatory Dietary Interventions in Rheumatoid Arthritis
Abstract Number: 0264

Distinct Multi-omic Signature Predicts Post-MMF Withdrawal Flares in Systemic Lupus Erythematosus Patients
Abstract Number: 2494

Distinct Organ Involvement and Outcome Profiles in Diffuse versus Limited Juvenile Systemic Sclerosis: Updated Results from the Juvenile Systemic Scleroderma Inception Cohort.
Abstract Number: 0969

Distinct Peripheral Adaptive Immune-Cell Signatures in Anti-MDA5-Positive Dermatomyositis-Related ILD versus Anti-Synthetase Syndrome-Related ILD
Abstract Number: 0614

Distinct Physiological Profiles Identified in Pediatric Patients with Amplified Musculoskeletal Pain Syndrome
Abstract Number: 2868

Distinct Plasma Cytokine Profiles Across Rheumatic Diseases Reveal an RA-Specific Interstitial Lung Disease Signature
Abstract Number: 2360

Distinct recruitment patterns in Sjogren’s disease and systemic lupus erythematosus: early referral versus disease activity surveillance
Abstract Number: 2327

Distinct vascular programmes characterise immune-mediated rheumatic diseases: Vasculopathy and remodelling in systemic sclerosis versus inflammatory angiogenesis in psoriatic arthritis
Abstract Number: 1829

Distinguishing bisphosphonate treatment induced bone marrow changes on whole body MRI from disease activity in patients with chronic nonbacterial osteomyelitis
Abstract Number: 0082

Divergent Immunomodulatory Effects of Covalent and Competitive TGF-β-Activated Kinase 1 Inhibitors in Rheumatoid Arthritis
Abstract Number: 0028

Divergent Roles for Classical and Non-Classical Monocytes in the Development of a Multi-Organ Murine Model of Systemic Sclerosis
Abstract Number: 0594

DMARD Use Is Associated With the Broadest Reduction in Hidradenitis Suppurativa Multidomain Disease Burden: A Cross-Sectional Analysis of a Community Health Survey Stratified by Rheumatic Comorbidity
Abstract Number: 2069

DNA Methylation Differences by SSA Serostatus in the Sjögren’s International Collaborative Clinical Alliance
Abstract Number: 1780

Do Changes in PET Activity Reflect Pulmonary Function Response in Sarcoidosis? A Retrospective Cohort Study
Abstract Number: 2328

Do Coping Strategies Impact Health Outcome Domains Over Time in Patients with Longstanding axSpA?
Abstract Number: 1564

Do Glucagon-like peptide-1 Based Therapies Increase the Risk of Adverse Effects in Those Taking Oral Bisphosphonates for Osteoporosis? (Encore presentation, previously an oral presentation at EULAR London 2026)
Abstract Number: 2646

Do Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Incident Gout in Type 2 Diabetes? Results of a Two-Cohort Real-World Active-Comparator Analysis
Abstract Number: 2521

Do Type II Symptoms Predict Complementary and Integrative Health Usage Among People Living with Systemic Lupus Erythematosus?
Abstract Number: 2394

Do We Have The Nerve To Treat Rheumatoid Arthritis? A Systematic Review and Meta-Analysis of Safety and Efficacy of Vagal Nerve Stimulation in Rheumatoid Arthritis Patients.
Abstract Number: 2105

Does early DMARD initiation modify relapse risk in giant cell arteritis? A real-world cohort study
Abstract Number: 1079

Does Having Preexisting Rheumatologic Disease Increase the Risk of Immune Related Adverse Events While on Immune Checkpoint Inhibitor Therapy? (Encore presentation, previously an oral presentation at EULAR London 2026)
Abstract Number: 1679

Does Hormone Replacement Therapy in Transgender Patients Affect the Risk of Developing Rheumatologic and Autoimmune Disease?
Abstract Number: 2329

Does Persistent Inflammation Predict Lumbar Syndesmophytes in Biologic-Treated Axial Spondyloarthritis?
Abstract Number: 1721

Does use of GLP-1 medications decrease care contact days for knee osteoarthritis? A retrospective analysis of Medicaid data.
Abstract Number: 0723

Domain-Level Discordance Between MDHAQ Patient-Reported Outcomes and Physician Documentation
Abstract Number: 0843

Domain-Specific Functional Impairment and Disease Burden in Chinese Psoriatic Arthritis: HAQ-DI Findings From the CREPAR Registry
Abstract Number: 0565

Domains of Health-Related Quality of Life Most Valued by Children with Vasculitis and their Caregivers
Abstract Number: 2574

Don’t Prosth-hesitate: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis of Synovial D-Lactate for Prosthetic Joint Infection in 1,328 Prosthetic Joint Infection Patients
Abstract Number: 2563

Dose Response, Immunogenicity, and Clinical Outcomes Following Intraarticular IL-1Ra Gene Therapy (PCRX-201) in Knee Osteoarthritis: a Phase 1 Study With 104-Week Follow-up
Abstract Number: 0737

Double Trouble: A Retrospective Chart Review of Patients with Immune-Related Myositis and Myasthenia Gravis
Abstract Number: 2890

Double-negative B-cell expansion predicts relapse in newly diagnosed giant cell arteritis
Abstract Number: 2245

Drug-Induced Lupus: A Comprehensive Review of Causative Agents and Clinical Manifestations
Abstract Number: 1986

DS-7011a, an Anti-TLR7 Monoclonal Antibody, Broadly Suppresses Immune Cell Signatures in SLE: Biomarker Findings from a Phase 1b/2 Study
Abstract Number: 0265

Dual CD19/BCMA Targeting CAR-T therapy Induces Deeper B-Cell Eradication, Complete Immune Reset, and Superior Remission Outcomes Compared to Single-Target CD19 CAR-T Therapy in Systemic Lupus Erythematosus and Lupus Nephritis
Abstract Number: 0070

Dual IL-17A/IL-17F Inhibition Modulates Entheseal Stromal Inflammatory Networks and Reveals a Role for IL-17F in Neutrophil Recruitment in Human Entheseal Inflammation
Abstract Number: 2082

Dual Inflammatory-Humoral Pathway Blockade by KD6005 Suppresses Autoantibody Production and Prevents Target Organ Damage across Autoimmune Disease Models
Abstract Number: 0518

Dual-Axis CD19/BCMA CAR T-Cell Therapy in Refractory Systemic Sclerosis-Overlap Connective Tissue Disease: Target Engagement, Skin Improvement, and Humoral Immune Reset
Abstract Number: 0634

Durable Clinical Efficacy of an Innovative Intra-Articular Apoptotic Cell Therapy in Knee Osteoarthritis: Age-Related Effect Through One Year
Abstract Number: 1216

Durable drug-free state, reduced infectious burden and a revamped B-cell environment several years after CD19-CAR-T cell therapy in SLE
Abstract Number: 0902

Durable One-Year Immunomodulatory-Free Clinical Responses Following a Single Infusion of Rese-cel (Resecabtagene Autoleucel) in Refractory Dermatomyositis
Abstract Number: 2246

Dysregulated Peripheral Mucosal-Associated Invariant T Cells in Systemic Lupus Erythematosus: Pro-inflammatory Reprogramming and Potential as Biomarkers for Disease Activity and Treatment Response
Abstract Number: 1997

Dysregulation of sphingosine-1-phosphate signaling in systemic lupus erythematosus and its therapeutic implications
Abstract Number: 2425

Dysregulation of the WNT Signalling Axis and Its Correlation with Disease Activity in Elderly Rheumatoid Arthritis Patients With and Without Osteoporosis- A Cross-Sectional Study